Creative Medical Technology Holdings, Inc.
CELZ · NASDAQ
Bulios Fair Price
$1.36
50.2% upside
Current Price
$0.91
According to Bulios Fair Price, CELZ is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Creative Medical Technology Holdings, Inc. (CELZ) shares could be suitable for investors looking to invest in the biotechnology and regenerative medicine sector. The company's focus on research and development of therapeutic solutions for the treatment of various diseases positions it as a key player in the field of biotechnology and regenerative medicine. Known for its efforts to harness modern technologies to support tissue self-regeneration and treat chronic illnesses, Creative Medical Technology Holdings, Inc. aims to provide innovative treatment options and enhance the quality of life for patients.
Sector
Healthcare
Industry
Biotechnology
CEO
Timothy Warbington
Employees
4
Headquarters
Phoenix
Upcoming events
Earnings
Upcoming earnings report